SLS Invest AB
Overview
SLS Invest AB is a Scandinavian venture capital firm specializing in life sciences investments. The firm operates as an evergreen structure, seeking significant ownership stakes in companies with proven business models and innovative products addressing substantial medical needs. SLS Invest primarily focuses on biotechnology, medical devices, pharmaceuticals, healthcare, and life sciences sectors. The firm's investment strategy encompasses both early and late-stage ventures, with a geographical focus on Sweden and Denmark. SLS Invest has a history of substantial investments, including a SEK 80 million investment in Swedish biotechnology company Gyros, resulting in an 88% ownership stake. SLS Invest's portfolio includes companies such as Light Sciences Oncology, AdvanDx, and OxThera, reflecting its commitment to advancing innovative solutions in the life sciences sector. The firm is headquartered in Stockholm, Sweden, and operates with a dedicated team of professionals committed to fostering growth in the life sciences industry.
Investment Focus
- Proven business model
- Innovative products addressing significant medical needs
- Focus on life sciences sectors
Portfolio Companies
Reach SLS Invest AB directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about SLS Invest AB
What sectors does SLS Invest AB invest in?
SLS Invest AB invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Stockholm County, Sweden. SLS Invest AB is listed as a venture capital in the ConnectSafely investor database.
What stage does SLS Invest AB invest at?
SLS Invest AB backs companies at Early Stage and Late Stage, writing cheques of 1M - 50M.
Which regions does SLS Invest AB invest in?
SLS Invest AB invests across Denmark and Sweden.
What companies has SLS Invest AB invested in?
SLS Invest AB's portfolio includes OxThera, Light Sciences Oncology and AdvanDx.
Last updated · Source: ConnectSafely investor database
